June 12, 2007; 68 (24 suppl 4) Introduction
Treatment strategies across the multiple sclerosis lifespan
Amy Perrin Ross
First published June 11, 2007, DOI: https://doi.org/10.1212/01.wnl.0000277701.66491.c4
Treatment strategies across the multiple sclerosis lifespan
Amy Perrin Ross
Neurology Jun 2007, 68 (24 suppl 4) S1-S2; DOI: 10.1212/01.wnl.0000277701.66491.c4
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 68 no. 24 suppl 4 S1-S2
Print ISSN:
Online ISSN:
History:
- First Published June 11, 2007.
Copyright & Usage:
© 2007
Author Disclosures
- Amy Perrin Ross, APRN, MSN, CNRN, MSCN
- Amy Perrin Ross, APRN, MSN, CNRN, MSCN
- From the Loyola University Medical Center, Maywood, Illinois.
- Address correspondence and reprint requests to Ms. Amy Ross, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL 60153 APerrin{at}lumc.edu
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Special Article
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S. Day, Ruth Ann Marrie et al.Neurology, April 23, 2018 -
Views & Reviews
Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MSJohn R. Corboy, Brian G. Weinshenker, Dean M. Wingerchuk et al.Neurology, April 23, 2018 -
Articles
Evidence-based medicine and clinical trialsPatricia K. Coyle et al.Neurology, June 11, 2007 -
Articles
Treatment of pediatric multiple sclerosis and variantsD. Pohl, E. Waubant, B. Banwell et al.Neurology, April 16, 2007